MSK Library
banner
msklibrary.bsky.social
MSK Library
@msklibrary.bsky.social
Medical Library of @mskcancercenter.bsky.social
- Tweets and posts are written by library staff and reflect their personal opinions not necessarily those of MSK.
Whether you’re quietly listening or actively making music, your brain lights up with reward and emotion centers, weaving together memory, motivation and well‑being. 🎶🎶🎶
December 16, 2025 at 6:24 PM
Synapse: Your Connection to our MSK Authors.
Meet: Chhavi Kumar
Research Focus: Medicine; Attending

Responsible Artificial Intelligence governance in oncology
synapse.mskcc.org/synapse/work...

#ResponsibleAI #AIGovernance #Oncology #EthicalAI #CancerCare #HealthPolicy #ClinicalAI
December 16, 2025 at 6:22 PM
Synapse: Your Connection to our MSK Authors.
Meet: Jeho Jeong
Research Focus: Medical Physics; Associate Attending

A streamlined workflow for comprehensive 4DCT imaging QA with automated analysis of spatial integrity and image quality
synapse.mskcc.org/synapse/work...

#RadiationOncology
December 15, 2025 at 2:57 PM
Synapse: Your Connection to our MSK Authors.
Meet: Kishwer S Nehal
Research Focus: Medicine; Attending

Patient-reported quality of life and esthetic satisfaction continues to improve for 1-year after Mohs surgery: A multicenter prospective cohort study
synapse.mskcc.org/synapse/work...
December 12, 2025 at 5:45 PM
Synapse: Your Connection to our MSK Authors.
Meet: Michael Forman Berger
Research Focus: Laboratory Medicine; Chief Attending

AI cancer driver mutation predictions are valid in real-world data

#AICancerResearch #CancerGenomics
#DriverMutations #RealWorldData #PrecisionOncology
#AIInMedicine
December 11, 2025 at 6:25 PM
Synapse: Your Connection to our MSK Authors.
Meet: Debyani Chakravarty
@CDebyaniPhD
Research Focus: AI cancer driver mutation predictions are valid in real-world data
synapse.mskcc.org/synapse/work...

#AIMutationPrediction #CancerGenomics #RealWorldData #AIDrivenOncology #PrecisionOncology
December 10, 2025 at 7:21 PM
Synapse: Your Connection to our MSK Authors.
Meet: Puneeth Iyengar
Research Focus: Radiation Oncology; Attending

Impact of a dedicated inpatient radiation oncology consult service on goal-concordant care
synapse.mskcc.org/synapse/work...

#RadiationOncology #InpatientCare
#ClinicalOutcomes
December 9, 2025 at 5:31 PM
The Holiday Hallway, which opens today has been a staple of December at MSK since 1993. But did you know that we have celebrated the holidays for many years before then? These pictures from the 1950s show our MSK nursing team putting up festive decorations in various wards of the hospital.
December 8, 2025 at 6:03 PM
AI reviewers are here — we are not ready

Artificial intelligence promises rapid and polite feedback on papers — but we must first review the reviewer.
nature.com/articles/d41...
#AIReviewers #WeAreNotReady #FutureOfPeerReview
#AIEthics #ScholarlyPublishing
#ResearchIntegrity #AcademicAI
AI reviewers are here — we are not ready
Artificial intelligence promises rapid and polite feedback on papers — but we must first review the reviewer.
nature.com
December 8, 2025 at 4:29 PM
Synapse: Your Connection to our MSK Authors.
Meet: Jonathan Agner Forsberg
Research Focus: Surgery; Attending

Does transhumeral osseointegration after amputation improve patient-reported outcomes and prosthesis use?
synapse.mskcc.org/synapse/work...

#Osseointegration #TranshumeralAmputation
December 5, 2025 at 6:08 PM
Synapse: Your Connection to our MSK Authors.
Meet: Kelsey E. Breen
Research Focus: Medicine; Lead Genetic Counselor

Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum
#AcuteMyeloidLeukemia #AML #Cytarabine

synapse.mskcc.org/synapse/work...
December 4, 2025 at 5:04 PM
Synapse: Your Connection to our MSK Authors.
Meet: Martin Stuart Tallman
Research Focus: Medicine; NE Retired Faculty

Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

#AcuteMyeloidLeukemia #AML

synapse.mskcc.org/synapse/work...
December 3, 2025 at 6:19 PM
Coming Soon–MSK’s EndNote is updating to EndNote 2025. It’s a light upgrade, no big workflow changes, but now includes new gen AI features. Reviewed by AIGC + listed in the MSK AI Registry. Please see the link below for additional information.

library.mskcc.org/blog/2025/12...
December 3, 2025 at 6:08 PM
It's Giving Tuesday!!! Today, we celebrate the power of generosity and community. Please support the work that empowers patients, caregivers, and staff to learn, discover, and thrive while most important focusing on our mission to save lives.
giving.mskcc.org
#MSKLibrary #GivingTuesday #Support
Donate to Memorial Sloan Kettering Cancer Center | MSK Giving
Your generosity helps us change how the world treats cancer. Make a donation, find an event, or create a fundraiser to help us continue our remarkable progress.
giving.mskcc.org
December 2, 2025 at 6:33 PM
Synapse: Your Connection to our MSK Authors.
Meet: Alison Michele Schram @aschramm.bsky.social
Research Focus: Medicine; Associate Attending

PYNNACLE phase II clinical trial protocol: Rezatapopt (PC14586) monotherapy in advanced or metastatic solid tumors
synapse.mskcc.org/synapse/work...
December 2, 2025 at 5:57 PM
Synapse: Your Connection to our MSK Authors.
Meet: Kristen Victor
Research Focus: SKI Pediatrics; Senior Research Technician

Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage
synapse.mskcc.org/synapse/work...

#Tregs #Thymus #ImmuneRepair #TCell
November 25, 2025 at 5:26 PM
Synapse: Your Connection to our MSK Authors.
Meet: Dr. Charles Rudin
Research Focus: Corporate; Deputy Director, Cancer Center

IDeate-Lung02: A phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer

synapse.mskcc.org/synapse/work...
#LungCancer
November 24, 2025 at 7:24 PM
The @FDA has fully approved tarlatamab (Imdelltra®), a targeted immunotherapy for adults with advanced small cell #lungcancer (#SCLC) that has progressed after platinum-based chemo.

The approval is based on an international phase 3 trial led by MSK’s Dr. Charles Rudin.

Learn more: bit.ly/44vKjYm
FDA Grants Full Approval to Lung Cancer Drug Tarlatamab Based on Trial Led by MSK Researcher
The U.S. Food and Drug Administration (FDA) has granted full approval to the drug tarlatamab, a bispecific T cell engager, for small cell lung cancer, based on results from a phase 3 clinical trial le...
bit.ly
November 24, 2025 at 6:22 PM
Synapse: Connection to our MSK Authors.
Meet: Colette Ngozi Owens
Research Focus: Medicine; Asst Attending

Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
synapse.mskcc.org/synapse/work...
November 21, 2025 at 4:27 PM
Synapse: Your Connection to our MSK Authors.
Meet: Mark Awad
Research Focus: Medicine; Chief, Assoc Attend

Distinct clinicogenomic features and immunotherapy associations in pulmonary sarcomatoid carcinoma: A multicenter retrospective study
synapse.mskcc.org/synapse/work...

#CancerResearch
November 20, 2025 at 5:28 PM
Synapse: Your Connection to our MSK Authors.
Meet: Molly Parsons Hogan
Research Focus: Radiology; Assistant Attending

Adaptive beast MRI scanning using AI
synapse.mskcc.org/synapse/work...

#AdaptiveMRI #BreastMRI #AIMedicalImaging
#AIinRadiology #BreastCancerScreening #Radiology
#AI
November 19, 2025 at 4:28 PM
Synapse: Your Connection to our MSK Authors.
Meet: Jose Ricardo Otazo Torres
Research Focus: Medical Physics; Vice Chairman Attending

High-definition motion-resolved MRI using 3D radial kooshball acquisition and deep learning spatial-temporal 4D reconstruction
synapse.mskcc.org/synapse/work...
November 18, 2025 at 4:12 PM